Author

Beyza Cengiz

Oregon Health & Science UniversityORCID 0000-0002-8699-0118Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

GEORGE V. THOMASiD· 1 shared Jessie May Cartier· 1 shared Kazumi H EckensteiniD· 1 shared Mark R. FloryiD· 1 shared Matthew E.K. ChangiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

GEORGE V. THOMASORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mitochondrial Translation Inhibition Uncovers a Critical Metabolic-Epigenetic Interface in Renal Cell Carcinoma

Kazumi H Eckenstein, Beyza Cengiz, Matthew E.K. Chang, Jessie May Cartier, Mark R. Flory, GEORGE V. THOMAS

This study shows that tigecycline inhibits mitochondrial translation in RCC, disrupts bioenergetics, and synergizes with entinostat to enhance anti-tumor effects.

Metabolites · Jun 12, 2025Peer-reviewedCancer Biology